Home › Funds › Farallon Capital Management › CTOR
Farallon Capital Management position in CTOR
CLOVIS ONCOLOGY INC · Health Care
Latest position (Q3 2022)51.91M sh
Reported value held$34.59M
Portfolio Weight0.22%
First reportedQ3 2021
Last changeHold
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 51.91M | $37.51M | New |
| Q4 2021 | 51.91M | $36.47M | Hold |
| Q1 2022 | 51.91M | $38.93M | Hold |
| Q2 2022 | 51.91M | $37.12M | Hold |
| Q3 2022 | 51.91M | $34.59M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding CTOR
- Bank of America Corp 3.84M sh · $2.49M · Q2 2026
- Vanguard Group 597.00K sh · $597.00K · Q4 2025
- UBS Group AG 334.62K sh · $217.50K · Q2 2026
- Geode Capital Management 245.41K sh · $159.54K · Q2 2026
- Citadel Advisors 90.59K sh · $58.89K · Q2 2026
- Northern Trust Corp 45.75K sh · $29.74K · Q2 2026
- Wells Fargo & Co 500 sh · $325 · Q2 2026
- Morgan Stanley 23 sh · $15 · Q2 2026